These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

33 related articles for article (PubMed ID: 2959076)

  • 1. Immunological studies on thromboxane synthase.
    Shen RF; Tai HH
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17A():34-8. PubMed ID: 2959076
    [No Abstract]   [Full Text] [Related]  

  • 2. Monoclonal antibodies to thromboxane synthase from porcine lung. Production and application to development of a tandem immunoradiometric assay.
    Shen RF; Tai HH
    J Biol Chem; 1986 Sep; 261(25):11585-91. PubMed ID: 3745157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production and characterization of polyclonal and monoclonal antibodies against human thromboxane synthase.
    Nüsing R; Wernet MP; Ullrich V
    Blood; 1990 Jul; 76(1):80-5. PubMed ID: 2364175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The localization of thromboxane synthase in normal and pathological human kidney tissue using a monoclonal antibody Tü 300.
    Nüsing R; Fehr PM; Gudat F; Kemeny E; Mihatsch MJ; Ullrich V
    Virchows Arch; 1994; 424(1):69-74. PubMed ID: 7981906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Sodium ferulate is an inhibitor of thromboxane A2 synthetase].
    Wang Z; Gao YH; Huang RS; Zhu GQ
    Zhongguo Yao Li Xue Bao; 1988 Sep; 9(5):430-3. PubMed ID: 3218538
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of BM-573 [N-terbutyl-N'-[2-(4'-methylphenylamino)-5-nitro-benzenesulfonyl]urea], a dual thromboxane synthase inhibitor and thromboxane receptor antagonist, in a porcine model of acute pulmonary embolism.
    Ghuysen A; Lambermont B; Dogné JM; Kolh P; Tchana-Sato V; Morimont P; Magis D; Hanson J; Segers P; D'Orio V
    J Pharmacol Exp Ther; 2004 Sep; 310(3):964-72. PubMed ID: 15121765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelin-1 releases endothelium-derived endoperoxides and thromboxane A2 in porcine coronary arteries with regenerated endothelium.
    Park SJ; Lee JJ; Vanhoutte PM
    Zhongguo Yao Li Xue Bao; 1999 Oct; 20(10):872-8. PubMed ID: 11270983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BM-573, a dual thromboxane synthase inhibitor and thromboxane receptor antagonist, prevents pig myocardial infarction induced by coronary thrombosis.
    Rolin S; Petein M; Tchana-Sato V; Dogne JM; Benoit P; Lambermont B; Ghuysen A; Kolh P; Masereel B
    J Pharmacol Exp Ther; 2003 Jul; 306(1):59-65. PubMed ID: 12721335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beneficial effect of donor pretreatment with thromboxane A2 synthase inhibitor on the graft survival in pig liver transplantation.
    Yokoyama I; Negita M; Kobayashi T; Hayashi S; Hachisuka T; Sato E; Orihara A; Uchida K; Takagi H
    J Surg Res; 1996 Jan; 60(1):232-8. PubMed ID: 8592420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative evaluation of thromboxane receptor blockade, thromboxane synthase inhibition and both in animal models of arterial thrombosis.
    Salvati P; Dho L; Ukmar G; Vaga L; Rimoldi O; Patrono C
    J Pharmacol Exp Ther; 1994 Apr; 269(1):238-45. PubMed ID: 8169831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitric oxide modulates the activity of the hemoproteins prostaglandin I2 synthase and thromboxane A2 synthase.
    Wade ML; Fitzpatrick FA
    Arch Biochem Biophys; 1997 Nov; 347(2):174-80. PubMed ID: 9367522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations in thromboxane synthase and thromboxane A2 receptors in experimental alcoholic liver disease.
    Nanji AA; Rahemtulla A; Maio L; Khwaja S; Zhao S; Tahan SR; Thomas P
    J Pharmacol Exp Ther; 1997 Aug; 282(2):1037-43. PubMed ID: 9262373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alternate splicing of human thromboxane synthase mRNA.
    Wang LH; Tazawa R; Lang AQ; Wu KK
    Arch Biochem Biophys; 1994 Dec; 315(2):273-8. PubMed ID: 7986068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thromboxane modulating agents. 3. 1H-imidazol-1-ylalkyl- and 3-pyridinylalkyl-substituted 3-[2-[(arylsulfonyl)amino]ethyl]benzenepropanoic acid derivatives as dual thromboxane synthase inhibitor/thromboxane receptor antagonists.
    Dickinson RP; Dack KN; Long CJ; Steele J
    J Med Chem; 1997 Oct; 40(21):3442-52. PubMed ID: 9341919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An antithrombotic agent, NQ301, inhibits thromboxane A2 receptor and synthase activity in rabbit platelets.
    Jin YR; Cho MR; Lee KS; Lee JJ; Lim Y; Han XH; Oh KW; Hong JT; Yoo HS; Yun YP
    Basic Clin Pharmacol Toxicol; 2005 Sep; 97(3):162-7. PubMed ID: 16128910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the new class I antiarrhythmic agent Ro 22-9194, (2R)-2-amino-N-(2,6-dimethylphenyl)-N-[3-(3-pyridyl)propyl]propionamide D-tartrate, on ischemia- and reperfusion-induced arrhythmias in dogs: involvement of thromboxane A2 synthase inhibitory activity.
    Murakami M; Kinukawa M; Kanazawa T; Maruyama K; Miyagi M; Miyata H; Ujiie A
    J Pharmacol Exp Ther; 1996 Nov; 279(2):877-83. PubMed ID: 8930195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of proaggregatory and antiaggregatory prostaglandins in hemostasis. Studies with combined thromboxane synthase inhibition and thromboxane receptor antagonism.
    Gresele P; Arnout J; Deckmyn H; Huybrechts E; Pieters G; Vermylen J
    J Clin Invest; 1987 Nov; 80(5):1435-45. PubMed ID: 2960694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human genes for prostaglandin endoperoxide synthase-2, thromboxane synthase and prostacyclin synthase.
    Tanabe T; Miyata A; Nanayama T; Tone Y; Ihara H; Toh H; Takahashi E; Ullrich V
    Adv Prostaglandin Thromboxane Leukot Res; 1995; 23():133-5. PubMed ID: 7732818
    [No Abstract]   [Full Text] [Related]  

  • 19. Guanidine derivatives as combined thromboxane A2 receptor antagonists and synthase inhibitors.
    Soyka R; Guth BD; Weisenberger HM; Luger P; Müller TH
    J Med Chem; 1999 Apr; 42(7):1235-49. PubMed ID: 10197967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological characterization of N-tert-butyl-N'-[2-(4'-methylphenylamino)-5-nitrobenzenesulfonyl]urea (BM-573), a novel thromboxane A2 receptor antagonist and thromboxane synthase inhibitor in a rat model of arterial thrombosis and its effects on bleeding time.
    Dogné JM; Hanson J; de Leval X; Kolh P; Tchana-Sato V; de Leval L; Rolin S; Ghuysen A; Segers P; Lambermont B; Masereel B; Pirotte B
    J Pharmacol Exp Ther; 2004 May; 309(2):498-505. PubMed ID: 14742735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.